Steigerwald Gordon & Koch’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.56M Sell
72,403
-17,576
-20% -$2.17M 0.88% 39
2025
Q4
$11.3M Sell
89,979
-24,471
-21% -$3.19M 1.09% 36
2025
Q3
$16.7M Sell
114,450
-3,358
-3% -$508K 1.61% 27
2025
Q2
$18.4M Buy
117,808
+1,138
+1% +$180K 1.94% 21
2025
Q1
$19.2M Buy
116,670
+67
+0.1% +$11.1K 2.14% 21
2024
Q4
$19M Buy
116,603
+2,418
+2% +$432K 2.15% 19
2024
Q3
$22.3M Buy
114,185
+5,198
+5% +$958K 2.43% 19
2024
Q2
$18.9M Buy
108,987
+11,743
+12% +$1.95M 2.29% 20
2024
Q1
$16.5M Buy
97,244
+3,617
+4% +$677K 2.05% 23
2023
Q4
$18.5M Buy
93,627
+2,261
+2% +$400K 2.5% 13
2023
Q3
$15.9M Buy
91,366
+2,549
+3% +$463K 2.42% 16
2023
Q2
$15.3M Buy
88,817
+2,465
+3% +$426K 2.24% 17
2023
Q1
$14.4M Buy
86,352
+3,685
+4% +$604K 2.15% 19
2022
Q4
$12.1M Buy
82,667
+6,185
+8% +$915K 1.93% 23
2022
Q3
$11.3M Buy
76,482
+25,903
+51% +$4.33M 2.08% 22
2022
Q2
$8.69M Buy
+50,579
New +$8.75M 1.52% 33

Other funds holding ZTS

Steigerwald Gordon & Koch's ZTS Position: Q1 2026 in Review

Steigerwald Gordon & Koch reduced its Zoetis (ZTS) stake by 20% in Q1 2026, selling an estimated $2.17M and leaving 72,403 shares worth $8.56M. The position accounts for 0.88% of the portfolio, ranked #39.

Steigerwald Gordon & Koch first reported a position in ZTS in Q2 2022 and has held it in 16 quarters since. The position peaked at $22.3M in Q3 2024. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Steigerwald Gordon & Koch held 72,403 shares of Zoetis worth $8.56M as of Q1 2026.
  • Steigerwald Gordon & Koch sold 17,576 Zoetis shares in Q1 2026, an estimated $2.17M.
  • Zoetis made up 0.88% of Steigerwald Gordon & Koch's portfolio in Q1 2026, its #39 holding.
  • Steigerwald Gordon & Koch first reported a position in Zoetis in Q2 2022 and has held it in 16 quarters since.
  • Steigerwald Gordon & Koch's Zoetis position peaked at $22.3M in Q3 2024.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q1 2026, filed 28 Apr 2026.